Results 201 to 210 of about 156,081 (291)

Δ9-Tetrahydrocannabinol does not upregulate an aversive dopamine receptor mechanism in adolescent brain unlike in adults. [PDF]

Curr Res Neurobiol, 2023
Di Raddo ME, Milenkovic M, Sivasubramanian M, Hasbi A, Bergman J, Withey S, Madras BK, George SR.   +7 more
europepmc   +1 more source

D1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system.

, 1988
K L Lankford, F G DeMello, W L Klein
openalex   +1 more source

Dopamine receptor subtypes colocalize in rat striatonigral neurons. [PDF]

, 1992
D. James Surmeier, James Eberwine, Charles J. Wilson, Richard Y. Cao, Alessandro Stefani, S.T. Kitai   +5 more
openalex   +1 more source

Silylation of Aryl and Alkyl Chlorides by a Seven‐Membered Dialkoxysilyl Group Si(pan)Me via an In Situ Generated Silylpotassium

Angewandte Chemie International Edition, EarlyView.
This study reveals a facile silylation protocol that enables the delivery of a stable and activatable dioxasilepanyl group, Si(pan)Me, to aryl and alkyl chlorides. Of note is the X‐ray structure of 18‐C‐6·K–Si(pan)Me, which elucidates a pivotal silylpotassium intermediate.
Kenshiro Hitoshio, Jun Shimokawa, Hideki Yorimitsu   +2 more
wiley   +1 more source

Disease-Associated Dopamine Receptor D2 Variants Exhibit Functional Consequences Depending on Different Heterotrimeric G-Protein Subunit Combinations. [PDF]

Biomedicines
Niebrügge N, Trovato O, Praschberger R, Lieb A.   +3 more
europepmc   +1 more source

Synthetic Approaches to Molecule‐2D Transition Metal Dichalcogenide Heterostructures

Angewandte Chemie International Edition, EarlyView.
The integration of 2D materials with molecular chemistry enables precise control over material properties and enhances their functionality. Molecule‐transition metal dichalcogenide (mTMD) heterostructures are particularly promising due to their unique electronic, optical, and catalytic properties.
Sofiia Zuieva, Xin Chen
wiley   +1 more source

PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement. [PDF]

Neuropsychopharmacology
Wong DF, Chand GB, Caito N, Eramo A, Grattan VT, Hixon MS, Nicol G, Lessie E, Prensky Z, Kuwabara H, Tian L, Valenta I, Schindler TH, Gründer G, Vaino AR.   +14 more
europepmc   +1 more source

Dopamine Receptor D₁R and D₃R and GRK4 Interaction in Hypertension. [PDF]

Yale J Biol Med, 2023
Zeng C, Armando I, Yang J, Jose PA.
europepmc   +1 more source

Suppression of dopamine receptor 2 inhibits the formation of human prostate cancer PC‑3‑derived cancer stem cell‑like cells through AMPK inhibition. [PDF]

Oncol Lett
Park J, Jang HJ, Jung WK, Kang DY, Gong YL, Kim HJ, Kang JS, Yang JW, Byun Y, Park SK.   +9 more
europepmc   +1 more source

Wolfram syndrome 1 regulates sleep in dopamine receptor neurons by modulating calcium homeostasis. [PDF]

PLoS Genet, 2023
Hao H, Song L, Zhang L.
europepmc   +1 more source